View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
Nivolumab 240 / Ipilimumab 1, Carcinoma of Unknown Primary
Protocol-ID: 3091 V1.0 (Mini), NIVO240/IPIL1, CUPIndication(s)
- Occult Primary Carcinoma; ICD-10 C80.0
TMB - Tumor Mutational Burden high
The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti. |
Valid since: 31.12.2025
